Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia

Background Despite the essential of understanding patterns of status epilepticus (SE) and investigating appropriate therapy for these patients, such data are limited in the Saudi population.Methods A retrospective study including adult patients who were admitted to emergency departments (EDs) in two...

Full description

Saved in:
Bibliographic Details
Main Authors: Sultan M. Alghadeer, Aseel Alsuwayegh, Hessa AlMuqati, Maha A. Alammari, Omar A. Almohammed
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2496797
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720615535116288
author Sultan M. Alghadeer
Aseel Alsuwayegh
Hessa AlMuqati
Maha A. Alammari
Omar A. Almohammed
author_facet Sultan M. Alghadeer
Aseel Alsuwayegh
Hessa AlMuqati
Maha A. Alammari
Omar A. Almohammed
author_sort Sultan M. Alghadeer
collection DOAJ
description Background Despite the essential of understanding patterns of status epilepticus (SE) and investigating appropriate therapy for these patients, such data are limited in the Saudi population.Methods A retrospective study including adult patients who were admitted to emergency departments (EDs) in two hospitals due to SE was conducted between May 2015 and July 2021. We aimed to describe the characteristics for patients who were admitted to ED with SE, describe the pattern of pharmacotherapy used in these patients, assess patients’ response to these pharmacotherapy agents in different stages and investigate reasons for treatment failure.Results A total of 420 SE episodes that received at least one dose of benzodiazepines (BDZs) or anti-seizure medications (ASMs) in ED were included. The mean age for them was 38.7 ±19.1 years and 89.0% had a history of epilepsy . BDZs or ASMs were used on first trial in 60.0% and 40.0% of episodes; and 20.6% and 84.5% (p < 0.0001) of these cases responded, respectively. The overall response to BDZs in all trials was 24.8% while it was 79.1% for the ASMs. The issue of under-dosing was more prevalent in BDZs’ compared to ASMs trials (63.4% vs. 19.6%) and was significantly associated with lack of response to therapy (86.6% vs. 0.0%; p < 0.0001).Conclusions There is an immanent need for educational, drug regulation awareness programs, and protocols enforcement policies that aims to optimize patient care by improving physicians’ adherence to clinical guidelines’ recommendations to improve the status of managing patients with SE in Saudi Arabia.
format Article
id doaj-art-86f05b03e38b4ec2a4e8264742cd697b
institution DOAJ
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-86f05b03e38b4ec2a4e8264742cd697b2025-08-20T03:11:53ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2496797Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi ArabiaSultan M. Alghadeer0Aseel Alsuwayegh1Hessa AlMuqati2Maha A. Alammari3Omar A. Almohammed4Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaPharmaceutical Care Services, King Saud University Medical City, Riyadh, Saudi ArabiaPharmaceutical Care Service, Ministry of the National Guard-Health Affairs, Riyadh, Saudi ArabiaPharmaceutical Care Service, Ministry of the National Guard-Health Affairs, Riyadh, Saudi ArabiaDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaBackground Despite the essential of understanding patterns of status epilepticus (SE) and investigating appropriate therapy for these patients, such data are limited in the Saudi population.Methods A retrospective study including adult patients who were admitted to emergency departments (EDs) in two hospitals due to SE was conducted between May 2015 and July 2021. We aimed to describe the characteristics for patients who were admitted to ED with SE, describe the pattern of pharmacotherapy used in these patients, assess patients’ response to these pharmacotherapy agents in different stages and investigate reasons for treatment failure.Results A total of 420 SE episodes that received at least one dose of benzodiazepines (BDZs) or anti-seizure medications (ASMs) in ED were included. The mean age for them was 38.7 ±19.1 years and 89.0% had a history of epilepsy . BDZs or ASMs were used on first trial in 60.0% and 40.0% of episodes; and 20.6% and 84.5% (p < 0.0001) of these cases responded, respectively. The overall response to BDZs in all trials was 24.8% while it was 79.1% for the ASMs. The issue of under-dosing was more prevalent in BDZs’ compared to ASMs trials (63.4% vs. 19.6%) and was significantly associated with lack of response to therapy (86.6% vs. 0.0%; p < 0.0001).Conclusions There is an immanent need for educational, drug regulation awareness programs, and protocols enforcement policies that aims to optimize patient care by improving physicians’ adherence to clinical guidelines’ recommendations to improve the status of managing patients with SE in Saudi Arabia.https://www.tandfonline.com/doi/10.1080/07853890.2025.2496797Status epilepticuspharmacotherapybenzodiazepinesanti-seizureresponseSaudi Arabia
spellingShingle Sultan M. Alghadeer
Aseel Alsuwayegh
Hessa AlMuqati
Maha A. Alammari
Omar A. Almohammed
Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
Annals of Medicine
Status epilepticus
pharmacotherapy
benzodiazepines
anti-seizure
response
Saudi Arabia
title Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
title_full Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
title_fullStr Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
title_full_unstemmed Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
title_short Underdosing and response to pharmacotherapy in patients with status epilepticus: a retrospective study from Saudi Arabia
title_sort underdosing and response to pharmacotherapy in patients with status epilepticus a retrospective study from saudi arabia
topic Status epilepticus
pharmacotherapy
benzodiazepines
anti-seizure
response
Saudi Arabia
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2496797
work_keys_str_mv AT sultanmalghadeer underdosingandresponsetopharmacotherapyinpatientswithstatusepilepticusaretrospectivestudyfromsaudiarabia
AT aseelalsuwayegh underdosingandresponsetopharmacotherapyinpatientswithstatusepilepticusaretrospectivestudyfromsaudiarabia
AT hessaalmuqati underdosingandresponsetopharmacotherapyinpatientswithstatusepilepticusaretrospectivestudyfromsaudiarabia
AT mahaaalammari underdosingandresponsetopharmacotherapyinpatientswithstatusepilepticusaretrospectivestudyfromsaudiarabia
AT omaraalmohammed underdosingandresponsetopharmacotherapyinpatientswithstatusepilepticusaretrospectivestudyfromsaudiarabia